Background and aims. There is evidence for the ability of antioxidants to counteract the effects of inflammation. We aimed to determine whether the administration of a lycopene/olives vegetation water compound might reduce prostatic inflammation and consequent lower urinary tract symptoms in patients with histologically proven prostatic inflammation. Methods. Over a month period, patients having undergone prostate biopsy and having been diagnosed with benign prostate were given lycopene/olives vegetarian water compound (Group A). Data were compared with those of a matched population of patients who did not receive such treatment (Group B). International prostate symptom score, peak flow rate and post-void residual were recorded before and at the end of treatment. Results. The 17 patients in group A and the 17 in group B, had similar age, PSA, prostate volume, peak flow rate and post-void residual, but patients in Group A had lower median international prostate symptoms score than those in group B (7 vs 12; p = 0.012). All patients in group A successfully completed treatment with no side effect. Group B experienced no difference in international prostate symptoms score, peak flow rate and post-void residual whereas group A experienced no difference in peak flow rate, a slight reduction in post-void residual and a decrease in international prostate symptoms score. Most important, reduction in international prostate symptoms score was significantly higher in group A than in group B (-2.0 vs 0, respectively; p = 0.0004). Conclusions. The lycopene/olives vegetation water compound seems to be effective in counteracting lower urinary tract symptoms due to prostatic inflammation.
A lycopene and olives vegetation water compound improves lower urinary tract symptoms in men with histologically-proven benign prostatic hyperplasia and inflammation
Selvaggio, O.;Sanguedolce, F.;Stallone, G.;Cormio, Luigi
2018-01-01
Abstract
Background and aims. There is evidence for the ability of antioxidants to counteract the effects of inflammation. We aimed to determine whether the administration of a lycopene/olives vegetation water compound might reduce prostatic inflammation and consequent lower urinary tract symptoms in patients with histologically proven prostatic inflammation. Methods. Over a month period, patients having undergone prostate biopsy and having been diagnosed with benign prostate were given lycopene/olives vegetarian water compound (Group A). Data were compared with those of a matched population of patients who did not receive such treatment (Group B). International prostate symptom score, peak flow rate and post-void residual were recorded before and at the end of treatment. Results. The 17 patients in group A and the 17 in group B, had similar age, PSA, prostate volume, peak flow rate and post-void residual, but patients in Group A had lower median international prostate symptoms score than those in group B (7 vs 12; p = 0.012). All patients in group A successfully completed treatment with no side effect. Group B experienced no difference in international prostate symptoms score, peak flow rate and post-void residual whereas group A experienced no difference in peak flow rate, a slight reduction in post-void residual and a decrease in international prostate symptoms score. Most important, reduction in international prostate symptoms score was significantly higher in group A than in group B (-2.0 vs 0, respectively; p = 0.0004). Conclusions. The lycopene/olives vegetation water compound seems to be effective in counteracting lower urinary tract symptoms due to prostatic inflammation.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.